-Scroll.in Terms of agreement give private players 30-year lease over parts of government district hospitals. Niti Aayog and the Union ministry for health and family welfare have proposed a model contract to increase the role of private hospitals in treating non-communicable diseases in urban India. The agreement, which has been been shared with states for their comments, allows private hospitals to bid for 30-year leases over parts of district hospital buildings...

-The Telegraph New Delhi: India's drug pricing rules allow companies to inflate the maximum retail prices of medicines, including life-saving drugs, costing patients thousands of additional rupees while offering slices of the profits to stockists, chemists, and hospitals. Quotations received by hospitals from drug companies' representatives offering discounts on maximum retail prices (MRPs) of medicines provide what some doctors and patients' rights advocates say is fresh evidence for excessive profiteering in India's...

-The Times of India NAGPUR: Farmers in Vidarbha should be encouraged to cultivate a variety of crops so that they could get a bigger market for their produce. In addition to this, promotion of organic farming will help in increasing the yield and curb farmers' suicides, said Vandana Shiva, a well-known scientist and environmentalist, on Wednesday. Addressing a press conference at Tilak Patrakar Bhavan, Shiva said, "Farmers and citizens of our country...

-The Times of India NEW DELHI: Acknowledging that women are a disadvantaged section despite comprising nearly half of the population of the country, the Centre is considering lowering income tax for single women, introducing Aadhaar-linked health cards for free basic health check-ups for women and cashless medical service for those who are pregnant. A national policy for women, framed by a group of ministers headed by external affairs minister Sushma Swaraj, is...

-The Telegraph New Delhi: The World Health Organisation has announced a plan to approve generic versions of two expensive bio-therapeutic anti-cancer molecules in an effort to make them available to low and middle-income countries. It said it would invite manufacturers to submit applications for pre-qualification of biologically similar versions of rituximab, used to treat chronic lymphocytic leukaemia and non-Hodgkin's lymphoma, and trastuzumab, used to treat breast cancer. The pre-qualification process is a mechanism...